1-1 of 1
Gamal Akabani
Close
Sort by
Journal Articles

Phase 1 trial study of 131 I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma

Clinical Trials & Observations
David A. Rizzieri, Gamal Akabani, Michael R. Zalutsky, R. Edward Coleman, Scott D. Metzler, James E. Bowsher, Bonnie Toaso, Elizabeth Anderson, Anand Lagoo, Steve Clayton, Charles N. Pegram, Joseph O. Moore, Jon P. Gockerman, Carlos DeCastro, Cristina Gasparetto, Nelson J. Chao, Darell D. Bigner
Journal: Blood
Blood (2004) 104 (3): 642–648.
https://doi.org/10.1182/blood-2003-12-4264
Published: 2004
Includes: Multimedia, Supplemental data